Metformin can reverse the downregulation of endometrial GLUT4 expression in PCOS patients by changing the expression of the androgen receptor (AR) in response to reduced levels of androgen [21], subsequently, which brought about subsequent changes in the insulin receptor/PI3K/Akt/mTOR signaling pathway. Here, SLC2A4 is linked to polycystic ovary syndrome.